| Literature DB >> 29234419 |
Juan Li1, Yu-Mei Zhang1, Jun-Yi Li1, Lv Zhu1, Hong-Xin Kang1, Hong-Yu Ren1, Huan Chen1, Ling Yuan1, Yi-Fan Miao1, Mei-Hua Wan1, Wen-Fu Tang1.
Abstract
BACKGROUND AND AIMS: Obesity has become the main public health issue nowadays with poor control and has been associated with increased risk of multiorgan disease, but the specific mechanism and effective medication are still to be addressed. Sheng-jiang powder (SJP) showed great potential in preventing obesity in Chinese researches but has no trace in English reports. This study was designed to investigate the effect of SJP on obesity and obesity-mediated multiorgan injuries.Entities:
Year: 2017 PMID: 29234419 PMCID: PMC5682060 DOI: 10.1155/2017/6575276
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Study design of feeding methods and the body weight and Lee's index of rats with high-fat diet feeding with/without Sheng-jiang powder (SJP) administration. Normal group (NG), obese group (OG), and SJP treatment group (SG). CD: chew diet; HFD: high-fat diet; NS: normal saline; SJP: Sheng-jiang powder. HF: high-fat diet feeding; HS: high-fat diet feeding and SJP administration. (a) Feeding and intervention methods of the study; (b) Lee's index of rats before sacrifice; (c) body weight of rats in the three experimental groups during the whole process of feeding. The whole study lasted 12 weeks with 10 weeks' administration of SJP (5 g/Kg) one time a day. All rats were sacrificed after 12 weeks' feeding. ∗ indicates that p < 0.05.
Expression of inflammatory indicators in tissues of rats in the three experimental groups.
| Organ | NG ( | OG ( | SG ( |
|---|---|---|---|
| Liver | |||
| MDA (pmol/ml) | 1730 ± 258 | 1755 ± 204 | 1788 ± 327 |
| ROS (IU/ml) | 672 ± 97 | 707 ± 45 | 767 ± 56 |
| SOD (U/ml) | 321 ± 26 | 275 ± 9 | 336 ± 51# |
| GSH-px (mIU/ml) | 83 ± 5 | 68 ± 4 | 93 ± 4# |
| Heart | |||
| MDA (pmol/ml) | 1287 ± 229 | 1826 ± 76 | 1512 ± 148# |
| SOD (U/ml) | 341 ± 38 | 363 ± 13 | 370 ± 12 |
| Spleen | |||
| MDA (pmol/ml) | 1403 ± 184 | 1535 ± 303 | 1455 ± 254 |
| SOD (U/ml) | 271 ± 42 | 151 ± 24 | 365 ± 20# |
| Lung | |||
| MDA (pmol/ml) | 1549 ± 158 | 1591 ± 227 | 1395 ± 166 |
| MPO (ng/ml) | 65 ± 9 | 69 ± 8 | 68 ± 6 |
| SOD (U/ml) | 315 ± 68 | 208 ± 26 | 301 ± 46# |
| Kidney | |||
| MDA (pmol/ml) | 1437 ± 45 | 1558 ± 135 | 1409 ± 215 |
| ROS (IU/ml) | 740 ± 164 | 362 ± 72 | 552 ± 60# |
| SOD (U/ml) | 283 ± 34 | 229 ± 15 | 218 ± 35 |
| GSH-px (mIU/ml) | 75 ± 19 | 98 ± 5 | 72 ± 7# |
| Intestine | |||
| MDA (pmol/ml) | 1452 ± 378 | 1475 ± 262 | 1591 ± 305 |
| MPO (ng/ml) | 68 ± 16 | 84 ± 4 | 46 ± 6# |
| SOD (U/ml) | 316 ± 38 | 319 ± 18 | 237 ± 27# |
| Pancreas | |||
| MDA (pmol/ml) | 346 ± 65 | 321 ± 83 | 235 ± 48# |
| SOD (U/ml) | 167 ± 19 | 153 ± 29 | 135 ± 38 |
MDA: malondialdehyde; SOD: superoxide dismutase; GSH-px: glutathione peroxidase; ROS: reactive oxygen species; MPO: myeloperoxidase. ∗ indicates that, compared with NG, p < 0.05; # means that, compared with OG, p < 0.05.
Figure 2The pathologic scores of rats' organs in all of the three experimental groups. ∗ indicates that p < 0.05.
Figure 3The histological images of rats' organs in all of the three experimental groups. Hematoxylin-eosin counterstain. Histological images are presented with original magnification 200x. The histological images of rats' organs from (a)–(c) exhibited tissue damage of rats in NG, OG, and SG, separately. Distinct changes were observed in different organs of obese rats (b), including enlarged hepatocytes (yellow arrow), extensive vacuolization (orange arrow), inflammatory cells infiltration (blue arrow), tissue edema (green arrow), myocardial early infarction (brown arrow), follicular degeneration (purple arrow), and necrosis (black arrow). These histological changes were partly reversed by SJP administration for 10 weeks (5 g/Kg·bw/day) (c).